Skip to main content

Market Overview

Why Autolus And Cerus Traded Higher Today

Share:
Why Autolus And Cerus Traded Higher Today

Autolus Therapeutics (NASDAQ: AUTL) shares are trading higher on Monday after the company announced the publication of its new AUTO6 Phase 1 data in childhood neuroblastoma in Science Translational Medicine.

Autolus Therapeutics PLC is a biopharmaceutical company. It's engaged in the development of next-generation programmed T cell therapies for the treatment of cancer.

Autolus Therapeutics shares were trading up 6.70% at $10.25 at the time of publication on Monday. The stock has a 52-week high of $17.19 and a 52-week low of $3.

Cerus (NASDAQ: CERS) shares were trading higher after the company announced that the FDA approved its INTERCEPT blood system for cryoprecipitation.

Cerus Corp is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites.

Cerus shares traded higher but were down 0.46% at $6.55 at the time of publication on Monday. The stock has a 52-week high of $7.94 and a 52-week low of $2.71.

 

Related Articles (CERS + AUTL)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Small Cap Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com